Roche sells Vitamins and Fine Chemicals Division to DSM
Heerlen,NL,03-Sep-2002 Compelling strategic move for both companies The Swiss based healthcare group Roche and the Dutch life science products and performance materials company DSM announced today that DSM intends to acquire Roche’s vitamins and fine chemicals Division. On the basis of the discussions to date, the two companies have reached basic agreement on price and payment terms and expect subsequently to conclude on an exclusive basis a contract on all terms of the transaction.
The Roche division is the world’s leading supplier of vitamins and carotenoids with annual sales in 2001 of CHF 3.5 billion (EUR 2.4 billion). The division, which will become a unit of DSM, is a global business, headquartered in Kaiseraugst (Switzerland). It employs 7.500 people.
The total consideration of the transaction is EUR 2.25 billion. The present and future liabilities from the vitamin price fixing case will remain with Roche. After signing of the contract and before closing the transaction needs to be approved by antitrust authorities.
Other news from the department business & finance
